BRPI0812013A2 - formulações para administração oral de agentes terapêuticos e métodos relacionaods. - Google Patents
formulações para administração oral de agentes terapêuticos e métodos relacionaods.Info
- Publication number
- BRPI0812013A2 BRPI0812013A2 BRPI0812013A BRPI0812013A BRPI0812013A2 BR PI0812013 A2 BRPI0812013 A2 BR PI0812013A2 BR PI0812013 A BRPI0812013 A BR PI0812013A BR PI0812013 A BRPI0812013 A BR PI0812013A BR PI0812013 A2 BRPI0812013 A2 BR PI0812013A2
- Authority
- BR
- Brazil
- Prior art keywords
- formulations
- oral administration
- therapeutic agents
- related methods
- methods
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64030707P | 2007-05-25 | 2007-05-25 | |
US60/640,307 | 2007-05-25 | ||
US97670807P | 2007-10-01 | 2007-10-01 | |
US60/976,708 | 2007-10-01 | ||
US4147808P | 2008-04-01 | 2008-04-01 | |
US61/041,478 | 2008-04-01 | ||
PCT/CA2008/000975 WO2008144888A1 (en) | 2007-05-25 | 2008-05-23 | Formulations for the oral administration of therapeutic agents and related methods |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0812013A2 true BRPI0812013A2 (pt) | 2017-03-21 |
BRPI0812013A8 BRPI0812013A8 (pt) | 2018-02-06 |
BRPI0812013B1 BRPI0812013B1 (pt) | 2022-03-22 |
Family
ID=58343413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0812013-7A BRPI0812013B1 (pt) | 2007-05-25 | 2008-05-23 | Formulações para a administração oral de agentes terapêuticos e métodos relacionados |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0812013B1 (pt) |
-
2008
- 2008-05-23 BR BRPI0812013-7A patent/BRPI0812013B1/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BRPI0812013A8 (pt) | 2018-02-06 |
BRPI0812013B1 (pt) | 2022-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0908292A2 (pt) | "métodos e composições para administração oral de exenatida" | |
BRPI0817075A2 (pt) | núcleos de fármaco para liberação prolongada de agentes terapêuticos | |
DK2328601T3 (da) | Linaclotid-holdige formuleringer til oral indgivelse | |
BRPI0812562A2 (pt) | composições terapêuticas anti-cd20 e métodos | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
BRPI0819218A2 (pt) | Métodos, estojos e composições para administração de compostos farmacêuticos | |
DK2114531T3 (da) | Punktpropper og fremgangsmåder til indgivelse af terapeutiske midler | |
DK2692341T3 (da) | Misbrugs-resistent lægemiddelformulering | |
HK1142823A1 (en) | Formulations for the oral administration of therapeutic agents and related methods | |
BRPI0907077A2 (pt) | métodos e composições para administração oral de proteínas | |
BRPI0807544A2 (pt) | Sólido farmacêutico e dose de vacina | |
BRPI0913379A2 (pt) | formulações farmacêuticas sólidas compreendendo bibw 2992 | |
BRPI0720100A2 (pt) | Implemento para cuidado oral | |
BRPI0917444A2 (pt) | composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc | |
BRPI0822885A2 (pt) | Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral | |
BRPI0821732A2 (pt) | Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada | |
DK2049525T3 (da) | N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf | |
BRPI0916877A2 (pt) | composição farmacêutica e administração da mesma | |
EP1838291A4 (en) | PHARMACEUTICAL FORMULATIONS AND METHOD OF USE THEREOF | |
ZA200808114B (en) | Formulations of low dose non-steroidal anti-inflammatory drugs and betacyclodextrin | |
BRPI0719394A2 (pt) | Preparação medicinal sólida | |
CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. | |
BRPI1007484A2 (pt) | composição farmacêutica para administração oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |